GuruTrack
MDGL

MDGL

MADRIGAL PHARMACEUTICALS INC

Data as of 2026 Q2 (06-30) · 13F snapshot

Summary
MADRIGAL PHARMACEUTICALS INC (MDGL) is held as common stock by 7 tracked hedge-fund managers, with a combined reported value of ~$2.29B; the largest are Baker Bros. Advisors, John Paulson, Ken Griffin. 3 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 2 added, 4 trimmed, 1 closed. 1 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Cooling
Common-stock holders73 also report options
Congress trades1
Price$509.44vs quarter-end-5.12%
Sectors0
This quarter's moves
New0
Added2
Trimmed / sold5
Top holderBaker Bros. Advisors

Common-stock positions

PUT and CALL disclosures are excluded from these holder counts and values.

Value $1.15B5.8% of portfolio2,143,1312026 Q2

PUT / CALL disclosures

Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.

Value $50.47M— of portfolio94,0002026 Q2
Value $46.66M— of portfolio86,9002026 Q2
Value $19.33M— of portfolio36,0002026 Q2
Value $1.83M— of portfolio3,4002026 Q2
Value $1.18M— of portfolio2,2002026 Q2
Value $698.0K— of portfolio1,3002026 Q2

Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.